ABOUT MAXCYTE, INC.
MaxCyte® is at the forefront of cell engineering, providing the leading non-viral transfection platform powered by our Flow Electroporation® Technology, which is instrumental in the discovery and commercialization of cutting-edge cell-based therapies. The MaxCyte ExPERT™ electroporation platform combines unmatched scalability and transfection efficiency in virtually any cell line, enabling the use of manufacturing host cells for antibody expression from discovery to stable cell line development, saving time and resources. As a trailblazer in the cell engineering field for 25 years, we are committed to transforming the future of medicine and helping improve patient outcomes. Let MaxCyte be your partner in navigating the exciting landscape of new therapy development.
MAXCYTE E-BOOKS
-
![Antibodies GettyImages-1441786721]( "Accelerate Antibody Development And Production")
MaxCyte's electroporation platform accelerates therapeutic antibody development with scalable, high-efficiency transfection, enabling rapid transient protein expression, and IND-enabling studies in weeks.
FEATURED PRODUCTS
CONTACT INFORMATION
MaxCyte, Inc.
9713 Key West Avenue Suite 400
Rockville, MD 20850
UNITED STATES
Contact: Daniel Nguyen
